cyclosporine and Lupus Nephritis

cyclosporine has been researched along with Lupus Nephritis in 109 studies

Research

Studies (109)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	25 (22.94)	18.2507
2000's	30 (27.52)	29.6817
2010's	34 (31.19)	24.3611
2020's	20 (18.35)	2.80

Authors

Authors	Studies
Houssiau, FA; Parodis, I	1
Cohen, C; Nitschmann, S	1
Fotheringham, J; Mandrik, O; Pearson, SD; Thokala, P; Tice, JA	1
Guo, J; Hernandez, I; Newman, TV	1
Agboola, F; Chapman, RH; Fotheringham, J; Herron-Smith, S; Mandrik, O; Pearson, SD; Ren, S; Stevenson, MD; Thokala, P; Tice, JA	1
Rabelink, TJ; Teng, YKO	1
Lee, YH; Song, GG	1
Engelke, K; Huizinga, RB; Lerma, E; van Gelder, T	1
Hasegawa, E; Hoshino, J; Ikuma, D; Kinowaki, K; Kono, K; Mizuno, H; Oba, Y; Ohashi, K; Sawa, N; Sawamura, M; Sekine, A; Suwabe, T; Ubara, Y; Yamanouchi, M	1
Anders, HJ; Gaikwad, AB; Kale, A; Lei, Y; Shelke, V	1
Argolini, LM; Binda, V; Caporali, R; Carli, L; Doria, A; Elefante, E; Esposito, C; Frontini, G; Gatto, M; Gerosa, M; Messa, P; Moroni, G; Mosca, M; Saccon, F; Scotti, I; Tani, C	1
Podestà, MA; Ponticelli, C	1
Anders, HJ; Lei, Y; Loutan, J	1
Heo, YA	1
Arriens, C; Caster, DJ; Gibson, K; Ginzler, EM; Huizinga, RB; Kaplan, J; Lisk, L; Navarra, S; Parikh, SV; Randhawa, S; Romero-Diaz, J; Rovin, BH; Solomons, N; Teng, YKO	1
Clarke, J	1
Moroni, G; Ponticelli, C	1
van Gelder, T	1
Mejía-Vilet, JM; Romero-Díaz, J	1
Gojazadeh, M; Hajialilo, M; Khabbazi, A; Malek Mahdavi, A; Rasi Hashemi, SS; Sheikholeslami, M	1
Boripatkosol, P; Kasitanon, N; Louthrenoo, W	1
Chang, YL; Chou, YC; Hsu, CC; Liao, HT; Tsai, CY; Wu, TH; Yang, TH	1
da Silva, JAP; Inês, L; Jesus, D; Rodrigues, M	1
Isenberg, D; Sin, FE	1
Chen, T; Huang, H; Mao, Y; Yin, L; Zhou, W; Zhou, Z	1
Fujikawa, K; Fukui, S; Horai, Y; Ichinose, K; Igawa, T; Iwamoto, N; Kawakami, A; Kawashiri, SY; Kitamura, M; Koga, T; Matsuoka, N; Nakamura, H; Nishino, T; Nonaka, F; Origuchi, T; Sato, S; Shimizu, T; Tamai, M; Tsuboi, M; Umeda, M	1
Dooley, MA; Huizinga, RB; Lysenko, L; Navarra, SV; Pendergraft, WF; Romero-Diaz, J; Rovin, BH; Solomons, N; Tumlin, J	1
Craig, JC	1
Caplan, AL; Trachtman, H	1
Huizinga, RB; Rovin, BH; Solomons, N	1
Angthararak, S; Kitumnuaypong, T; Pichaiwong, W; Sumethkul, K	1
Chen, HH; Chen, YH; Chen, YM; Hsieh, CW; Hsieh, TY; Hsu, CY; Huang, WN; Hung, WT; Lai, KL; Liao, YW; Lin, CT; Tang, KT; Tseng, CW	1
Dall'Era, M; Federico, R; Solomons, N; Truman, M	1
Amano, K; Chino, K; Ito, T; Kato, H; Kondo, T; Kurasawa, T; Nagasawa, H; Nishi, E; Nishimura, K; Ogawa, H; Okuyama, A; Sakai, R; Shibata, A; Takei, H	1
Böhmova, J; Havrda, M; Horák, P; Hrncír, Z; Lukác, J; Olejárová, M; Rovensky, J; Rychlík, I; Rysavá, R; Sinikka Pesicková, S; Slatinská, J; Tegzova, D; Tesar, V; Vítová, J; Vlasáková, V; Zadrazil, J; Závada, J	1
Gladman, DD; Ibañez, D; Touma, Z; Urowitz, MB	1
Chan, TM	1
Aragon, E; Chan, YH; Lau, YW; Loh, HL; Ng, KH; Resontoc, LP; Tan, PH; Yap, HK	1
Ji, L; Qin, W; Tang, X; Yang, L; Zhang, X	1
Furie, R; Narain, S	1
Fernandez Nieto, M; Jayne, DR	1
Kronbichler, A; Mayer, G; Neumann, I	1
Bertsias, G; Boumpas, DT	1
Navaneethan, SD; Strippoli, GF; Viswanathan, G	1
Doria, A; Moroni, G; Ponticelli, C	1
Austin, HA; Balow, JE; Braun, MJ; Illei, GG	1
Amano, K; Kameda, H; Ogawa, H; Takeuchi, T	1
Chen, WS; Hsu, YH; Lee, HT; Shiao, YM; Tsai, CY; Tsai, SF; Wu, TH	1
Brugos, B; Dul, C; Gubisch, W; Kiss, E; Sipka, S; Szegedi, G; Zeher, M	1
Aragon, E; Chan, YH; Lau, YW; Ng, KH; Tan, PH; Yap, HK	1
Böhmova, J; Dostál, C; Hána, J; Havrda, M; Horák, P; Hrncír, Z; Lukác, J; Olejarova, M; Pesickova, S; Rovensky, J; Rychlík, I; Rysava, R; Tegzova, D; Tesar, V; Vítova, J; Zadrazil, J; Zavada, J	1
Hebert, LA; Rovin, BH	1
Okuyama, H; Yokoyama, H	1
Naito, T	1
Wu, XC; Zhou, DJ	1
Ehara, T; Hashimoto, K; Higuchi, M; Kamijo, Y; Shigematsu, H; Takahashi, K	1
Azmi, MT; Hamidon, BB; Kong, CT; Mohd Shahrir, MS; Sazliyana, S; Tan, HJ	1
Hussein, M; Mooij, J; Roujouleh, H	1
Dimitrijević, J; Novicić-Sasić, D; Palić-Obradović, D; Pavlović, S; Petrović, R; Prodanović, S; Stevanović, G; Stojanović, R; Stojković, D	1
Chen, H; Hu, W; Li, L; Li, S; Liu, Z; Shen, S; Yao, X	1
Chen, XW; Liang, D; Liu, HF; Pan, ZX; Tang, DS	1
Benedetti, E; Bogetti, D; Dong, G; Panaro, F; Rondelli, D; Sammartino, C; Sankary, H; Testa, G	1
Kogata, Y; Kumagai, S; Nakazawa, T	1
Akimoto, M; Aoki, N; Arima, N; Fujiwara, H; Hamada, H; Inoue, H; Kaieda, T; Matsushita, K; Ozaki, A; Satomura, A; Suruga, Y; Tei, C	1
Carreño, A; de la Torre, M; Rivera, F; Sánchez de la Nieta, MD	1
Baca, V; Catalán, T; Morales, AM; Ramón, G; Rodríguez-Leyva, F; Villasís-Keever, M	1
Fernández, J; Mellor-Pita, S; Tutor-Ureta, P; Yebra Bango, M	1
Brown, F; Carroll, RP; Kerr, PG	1
Fujinaga, S; Kaneko, K; Mochizuki, H; Ohtomo, Y; Shimizu, T; Takemoto, M; Umino, D; Yamashiro, Y	1
Dostal, C; Honsova, E; Jancova, E; Maixnerova, D; Merta, M; Rihova, Z; Rysava, R; Tesar, V; Vankova, Z	1
Amano, K; Kameda, H; Nagasawa, H; Ogawa, H; Sekiguchi, N; Takei, H; Takeuchi, T; Tsuzaka, K	1
Matsuo, S; Nishihara, G; Shimajiri, S; Uchida, E	1
Alberighi, OD; Altieri, P; Doria, A; Ferraccioli, G; Ferrara, R; Greco, S; Manno, C; Moroni, G; Mosca, M; Ponticelli, C; Todesco, S	1
Adam, AG; Al-Saaran, AM; Baddour, NM; El-Sehemy, MS; Moez, PE	1
Appel, GB; Kunis, C; Radhakrishnan, J; Valeri, A	1
Gotti, E; Remuzzi, G	1
Baelde, HJ; Bergijk, EC; Bruijn, JA; de Heer, E	1
Yang, XY; Yin, PD	1
Aswad, S; Bangsil, R; el-Shahawy, MA; Massry, SG; Mendez, R; Mendez, RG	1
Gergely, P	1
De Caterina, R	1
Appel, GB; D'Agati, V; Kunis, CL; Radhakrishnan, J	1
Hussein, MM; Mooij, JM; Roujouleh, H	1
Cui, X; Guo, Z; Lin, M; Yao, Q; Zheng, X; Zhou, G	1
Cağlar, S; Erdem, Y; Oymak, O; Turgan, C; Yalçin, AU; Yasavul, U	1
Chen, WP; Fu, LW; Lin, CY; Yang, LY	2
Amend, WJ; Criswell, LA; Millward, CL; Olson, JL; Stone, JH	1
Li, L; Tang, Z; Zhang, J; Zhang, S	1
Lai, FM; Leung, CB; Li, EK; Lui, SF; Szeto, CC; Tam, LS; Wang, A; Wong, KC	1
Appel, G; Klein, M; Radhakrishnan, J	1
Austin, HA; Balow, JE; Boumpas, DT; Fleisher, TA; Kim, Y; Piscitelli, S; Pucino, F; Tassiulas, IO; Vaughan, E	1
Baldissera, E; Bellone, M; Bozzolo, E; Ferrario, L; Sabbadini, MG	1
Hallegua, D; Klinenberg, JR; Metzger, AL; Rinaldi, RZ; Wallace, DJ	1
Danovitch, GM; Gritsch, HA; Lassman, C; Peng, A; Pham, PC; Pham, PT; Wilkinson, AH	1
Halevy, D; Radhakrishnan, J	1
Cobankiat, J; Lu, YM; Vathsala, A; Woo, KT	1
Anavi, BL; Dimitrakov, DJ; Kumchev, EP; Manev, EI; Nikolov, DG; Pandeva, SM; Tilkian, EE; Tzekov, VD; Tzvetkova, ZT	1
Fu, YF; Liu, GL	1
Lai, FM; Leung, CB; Li, EK; Lui, SF; Szeto, CC; Tam, LS; Wong, KC; Wong, SM	1
Chen, W; Liang, L; Liu, Y; Yang, X; Ye, Y; Yin, P; Yu, X; Zhan, Z	1
Meyrier, A	1
Daskalakis, P; Delaney, V; Friedman, EA; Hong, JH; Markell, M; Miles, AM; Sommer, BG; Sumrani, N	1
Balletta, M; Colucci, G; Di Luccio, R; Fuiano, G; Magri, P; Sabella, D; Sepe, V; Stanziale, P	1
Bonet, J; Borrás, M; Caralps, A; Lauzurica, R; Serra, A; Torguet, P; Vaquero, M	1
Cole, BR; Goss, JA; Hanto, DW; Jendrisak, MD; McCullough, CS; So, SK; Windus, DW	1
González, T; Hernández-Beriaín, JA; Rodríguez-Lozano, B	1
Appolinaire-Pilipenko, S; Dueymes, M; Fournié, GJ; In, S; Labarre, JF; Sournies, F	1

Reviews

28 review(s) available for cyclosporine and Lupus Nephritis

Article	Year
Voclosporin (Lupkynis) for lupus nephritis. The Medical letter on drugs and therapeutics, 2021, Aug-23, Volume: 63, Issue:1631 Topics: Administration, Oral; Animals; Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; T-Lymphocytes	2021
Comparative Efficacy and Safety of Tacrolimus, Cyclosporin A, Mycophenolate Mofetil, Cyclophosphamide, and Corticosteroids as Induction Therapy for Membranous Lupus Nephritis: A Network Meta-Analysis. Pharmacology, 2022, Volume: 107, Issue:9-10 Topics: Adrenal Cortex Hormones; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Mycophenolic Acid; Network Meta-Analysis; Tacrolimus; Treatment Outcome	2022
Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis. Expert review of clinical pharmacology, 2022, Volume: 15, Issue:5 Topics: Adult; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis	2022
Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis. Cells, 2023, 10-11, Volume: 12, Issue:20 Topics: Calcineurin Inhibitors; Cyclosporine; Humans; Lupus Nephritis	2023
B-cell depletion or belimumab or voclosporin for lupus nephritis? Current opinion in nephrology and hypertension, 2021, 03-01, Volume: 30, Issue:2 Topics: Antibodies, Monoclonal, Humanized; B-Lymphocytes; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Treatment Outcome	2021
Voclosporin: First Approval. Drugs, 2021, Volume: 81, Issue:5 Topics: Animals; Calcineurin Inhibitors; COVID-19; COVID-19 Drug Treatment; Cyclosporine; Drug Approval; Humans; Immunosuppressive Agents; Kidney Transplantation; Lupus Nephritis	2021
How cyclosporine reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not. Kidney international, 2021, Volume: 100, Issue:6 Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Tacrolimus	2021
Voclosporin: a novel calcineurin inhibitor for the management of lupus nephritis. Expert review of clinical immunology, 2021, Volume: 17, Issue:9 Topics: Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid	2021
An evaluation of voclosporin for the treatment of lupus nephritis. Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:14 Topics: Calcineurin Inhibitors; Clinical Trials as Topic; Cyclosporine; Dose-Response Relationship, Drug; Half-Life; Humans; Kaplan-Meier Estimate; Lupus Nephritis; Treatment Outcome	2018
Treatment of severe lupus nephritis: the new horizon. Nature reviews. Nephrology, 2015, Volume: 11, Issue:1 Topics: Antimalarials; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Nephritis; Mycophenolic Acid; Ribonucleosides; Severity of Illness Index; Sirolimus; Tacrolimus	2015
The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis. International urology and nephrology, 2016, Volume: 48, Issue:5 Topics: Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Randomized Controlled Trials as Topic; Tacrolimus	2016
Update on clinical trials in systemic lupus erythematosus. Current opinion in rheumatology, 2016, Volume: 28, Issue:5 Topics: Abatacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B-Lymphocytes; Clinical Trials as Topic; Cyclosporine; Herpes Zoster; Humans; Immunosuppressive Agents; Interferon Type I; Lupus Erythematosus, Systemic; Lupus Nephritis; Maintenance Chemotherapy; Peptide Fragments; Plasma Cells; Quinolones; Recombinant Fusion Proteins; Remission Induction; T-Lymphocytes; Tacrolimus; Treatment Outcome	2016
Update on the management of lupus nephritis: let the treatment fit the patient. Nature clinical practice. Rheumatology, 2008, Volume: 4, Issue:9 Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Controlled Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Rituximab	2008
Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Drugs, 2008, Volume: 68, Issue:15 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Oligonucleotides; Rituximab	2008
Cyclosporine (CsA) in lupus nephritis: assessing the evidence. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, Volume: 24, Issue:1 Topics: Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis	2009
Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care? Nephron. Clinical practice, 2011, Volume: 117, Issue:1 Topics: Autoimmune Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Tacrolimus	2011
[New insight into nephrotic lupus glomerulonephritis]. Nihon Jinzo Gakkai shi, 2010, Volume: 52, Issue:7 Topics: Azathioprine; Blood Component Removal; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Japan; Lupus Nephritis; Methylprednisolone; Prednisolone; Pulse Therapy, Drug	2010
[Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2010, Volume: 130, Issue:12 Topics: Animals; Antimetabolites; Calcineurin Inhibitors; Cyclosporine; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Glucuronides; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Lupus Nephritis; Mycophenolic Acid; Tacrolimus	2010
[Meta-analysis of calcineurin inhibitor in the treatment of lupus nephritis]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2011, Volume: 49, Issue:4 Topics: Calcineurin Inhibitors; Cyclosporine; Enzyme Inhibitors; Humans; Lupus Nephritis; Tacrolimus	2011
[Pharmacotherapy of SLE]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 5 Topics: Adrenal Cortex Hormones; Anemia, Hemolytic; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclophosphamide; Cyclosporine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Mycophenolic Acid; Plasma Exchange	2005
Use of cyclosporin in lupus nephritis. Contributions to nephrology, 1995, Volume: 114 Topics: Animals; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lupus Nephritis; Recurrence	1995
Omega 3 fatty acids in renal diseases. World review of nutrition and dietetics, 1994, Volume: 76 Topics: Chronic Disease; Cyclosporine; Fatty Acids, Omega-3; Glomerulonephritis, IGA; Humans; Hyperlipidemias; Kidney Diseases; Kidney Glomerulus; Lupus Nephritis	1994
Cyclosporine treatment of glomerular diseases. Annual review of medicine, 1999, Volume: 50 Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Drug Combinations; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Nephrotic Syndrome; Recurrence; Steroids	1999
Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Lupus, 2000, Volume: 9, Issue:4 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Treatment Outcome	2000
Cyclosporin treatment of glomerular diseases. Expert opinion on investigational drugs, 2000, Volume: 9, Issue:5 Topics: Animals; Cyclosporine; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; Immunosuppressive Agents; Lupus Nephritis; Nephrotic Syndrome	2000
Antiproteinuric and immunological effects of cyclosporin A in the treatment of glomerular diseases. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1992, Volume: 7 Suppl 1 Topics: Cyclosporine; Glomerulonephritis, IGA; Glomerulonephritis, Membranous; Humans; Immune System; Kidney Diseases; Lupus Nephritis; Nephrotic Syndrome; Proteinuria	1992
Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature. Transplantation, 1991, Volume: 52, Issue:5 Topics: Adult; Animals; Antibodies, Antinuclear; Antilymphocyte Serum; Azathioprine; Complement System Proteins; Cyclosporine; Graft Survival; Humans; Immunosuppression Therapy; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Muromonab-CD3; Prednisone; Rabbits	1991
[New approaches to the therapy of diffuse inflammatory diseases of the connective tissue]. Medicina clinica, 1991, Oct-05, Volume: 97, Issue:11 Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Connective Tissue Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymph; Methotrexate; Plasmapheresis; Synovitis	1991

Trials

20 trial(s) available for cyclosporine and Lupus Nephritis

Article	Year
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet (London, England), 2021, 05-29, Volume: 397, Issue:10289 Topics: Adult; Aged; Calcineurin Inhibitors; Creatinine; Cyclosporine; Double-Blind Method; Female; Glomerular Filtration Rate; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Treatment Outcome	2021
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis. Kidney international, 2019, Volume: 95, Issue:1 Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Remission Induction; Treatment Outcome; Young Adult	2019
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:4 Topics: Adolescent; Adult; Age of Onset; Cyclophosphamide; Cyclosporine; Female; Hematocrit; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Prednisone; Prognosis; Proteinuria; Serum Albumin; Young Adult	2009
Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice. Lupus, 2010, Volume: 19, Issue:2 Topics: Adolescent; Adult; Aged; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Proteinuria; Severity of Illness Index; Survival Rate; Treatment Outcome; Young Adult	2010
Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis. Lupus, 2010, Volume: 19, Issue:8 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Remission Induction; Retrospective Studies; Treatment Outcome	2010
Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study. Lupus, 2010, Volume: 19, Issue:11 Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Kidney Function Tests; Lupus Nephritis; Male; Survival Rate; Treatment Outcome; Young Adult	2010
Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis. Lupus, 2006, Volume: 15, Issue:8 Topics: Adolescent; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Proteinuria; Treatment Outcome	2006
Treatment of lupus nephritis with cyclosporine - an outcome analysis. Kidney & blood pressure research, 2007, Volume: 30, Issue:2 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Lupus Nephritis; Male; Treatment Outcome	2007
Prospective study of low-dose cyclosporine A in patients with refractory lupus nephritis. Modern rheumatology, 2007, Volume: 17, Issue:2 Topics: Adolescent; Adult; Antirheumatic Agents; Cyclosporine; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Prednisolone; Prospective Studies; Treatment Outcome	2007
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1, Issue:5 Topics: Administration, Oral; Adult; Azathioprine; Complement C3; Complement C4; Creatinine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Italy; Lupus Nephritis; Male; Methylprednisolone; Pilot Projects; Prednisone; Prospective Studies; Proteinuria; Severity of Illness Index; Time Factors; Treatment Outcome	2006
Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis. The Egyptian journal of immunology, 2006, Volume: 13, Issue:1 Topics: Adolescent; Adult; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Prospective Studies	2006
[A clinical study on low dose cyclosporin A in the treatment of lupus nephritis]. Zhonghua nei ke za zhi, 1994, Volume: 33, Issue:10 Topics: Adolescent; Adult; Blood Sedimentation; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Lupus Nephritis; Male; Middle Aged; Proteinuria; Serum Albumin	1994
Cyclosporine treatment of lupus membranous nephropathy. Clinical nephrology, 1994, Volume: 42, Issue:3 Topics: Adult; Biopsy; Cyclosporine; Drug Administration Schedule; Female; Humans; Kidney; Lupus Nephritis; Male; Pilot Projects; Recurrence; Time Factors	1994
Ciclosporin A in lupus nephritis. Nephron, 1996, Volume: 72, Issue:2 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Treatment Outcome	1996
Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis. British journal of clinical pharmacology, 1997, Volume: 44, Issue:2 Topics: Adolescent; Area Under Curve; Biological Availability; Capsules; Child; Chromatography, High Pressure Liquid; Cyclosporine; Emulsions; Humans; Immunosuppressive Agents; Lupus Nephritis	1997
Clinical efficacy of cyclosporin a neoral in the treatment of paediatric lupus nephritis with heavy proteinuria. British journal of rheumatology, 1998, Volume: 37, Issue:2 Topics: Adolescent; Antibodies, Antinuclear; Antirheumatic Agents; Child; Complement C3; Cyclophosphamide; Cyclosporine; DNA; Drug Therapy, Combination; Emulsions; Humans; Lupus Nephritis; Prednisolone; Proteinuria; Safety; Treatment Outcome	1998
Long-term treatment of lupus nephritis with cyclosporin A. QJM : monthly journal of the Association of Physicians, 1998, Volume: 91, Issue:8 Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Hemoglobins; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Prednisolone; Prospective Studies; Proteinuria; Serum Albumin	1998
Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Lupus, 2000, Volume: 9, Issue:4 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Treatment Outcome	2000
Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A. Lupus, 2001, Volume: 10, Issue:11 Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Middle Aged; Prednisone; Prospective Studies	2001
Ciclosporin plus steroids versus steroids alone in the treatment of lupus nephritis. Contributions to nephrology, 1992, Volume: 99 Topics: Creatinine; Cyclosporine; Drug Therapy, Combination; Humans; Lupus Nephritis; Prednisone; Proteinuria	1992

Other Studies

62 other study(ies) available for cyclosporine and Lupus Nephritis

Article	Year
From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift? Annals of the rheumatic diseases, 2022, Volume: 81, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Maintenance Chemotherapy; Precision Medicine; Remission Induction	2022
[Voclosporin for the treatment of lupus nephritis]. Der Internist, 2021, Volume: 62, Issue:10 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis	2021
The effectiveness and value of belimumab and voclosporin for lupus nephritis. Journal of managed care & specialty pharmacy, 2021, Volume: 27, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Cost-Benefit Analysis; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Models, Economic	2021
Emerging treatments for lupus nephritis: health equity considerations in clinical research and coverage. Journal of managed care & specialty pharmacy, 2021, Volume: 27, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Biomedical Research; Cost-Benefit Analysis; Cyclosporine; Drug Therapy; Health Equity; Humans; Immunosuppressive Agents; Insurance Coverage; Insurance, Health; Lupus Nephritis	2021
The Cost-Effectiveness of Belimumab and Voclosporin for Patients with Lupus Nephritis in the United States. Clinical journal of the American Society of Nephrology : CJASN, 2022, Volume: 17, Issue:3 Topics: Antibodies, Monoclonal, Humanized; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Quality-Adjusted Life Years; Renal Insufficiency; United States	2022
Will New Treatment Options for Lupus Nephritis Be Affordable? Clinical journal of the American Society of Nephrology : CJASN, 2022, Volume: 17, Issue:3 Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mycophenolic Acid	2022
Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis. Internal medicine (Tokyo, Japan), 2023, Apr-01, Volume: 62, Issue:7 Topics: Adult; Aged; Calcineurin Inhibitors; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Middle Aged; Nephrotic Syndrome; Prednisolone; Proteinuria	2023
Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up. Journal of nephrology, 2021, Volume: 34, Issue:2 Topics: Azathioprine; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Retrospective Studies; Treatment Outcome	2021
Calcineurin inhibitors in lupus nephritis. Journal of nephrology, 2021, Volume: 34, Issue:2 Topics: Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Tacrolimus	2021
Voclosporin improves outcomes in lupus nephritis. Nature reviews. Rheumatology, 2021, Volume: 17, Issue:7 Topics: Calcineurin Inhibitors; Cyclosporine; Humans; Lupus Nephritis	2021
AURORA 1 reports efficacy of voclosporin in lupus nephritis. Nature reviews. Nephrology, 2021, Volume: 17, Issue:10 Topics: Clinical Trials, Phase III as Topic; Cyclosporine; Humans; Lupus Nephritis; Treatment Outcome	2021
Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis. Modern rheumatology, 2018, Volume: 28, Issue:3 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Remission Induction	2018
Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria. International journal of rheumatic diseases, 2018, Volume: 21, Issue:1 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Opportunistic Infections; Proteinuria; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult	2018
Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus. Clinical nephrology, 2018, Volume: 89, Issue:4 Topics: Adult; Biopsy; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult	2018
Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis. Lupus, 2018, Volume: 27, Issue:8 Topics: Adult; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Middle Aged; Mycophenolic Acid; Portugal; Prednisolone; Proteinuria; Remission Induction; Retrospective Studies; Young Adult	2018
Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy. The Journal of international medical research, 2019, Volume: 47, Issue:1 Topics: Adolescent; Antibiotics, Antineoplastic; Child; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Mycophenolic Acid; Recurrence; Remission Induction; Retrospective Studies; Tacrolimus	2019
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis. Clinical immunology (Orlando, Fla.), 2018, Volume: 197 Topics: Adult; Creatinine; Cyclophosphamide; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Logistic Models; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Podocytes; Prednisolone; Prognosis; Proteinuria; Remission Induction; Retrospective Studies; Severity of Illness Index; Tacrolimus	2018
Interpreting trial results-time for confidence and magnitude and not P values please. Kidney international, 2019, Volume: 95, Issue:1 Topics: Cyclosporine; Double-Blind Method; Humans; Lupus Nephritis	2019
Data monitoring committees and randomized clinical trials. Kidney international, 2019, Volume: 95, Issue:4 Topics: Clinical Trials Data Monitoring Committees; Cyclosporine; Double-Blind Method; Humans; Lupus Nephritis; Randomized Controlled Trials as Topic; Research Design	2019
The authors reply. Kidney international, 2019, Volume: 95, Issue:4 Topics: Cyclosporine; Double-Blind Method; Humans; Lupus Nephritis	2019
Low-dose cyclosporine for active lupus nephritis: a dose titration approach. Clinical rheumatology, 2019, Volume: 38, Issue:8 Topics: Adult; Cohort Studies; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Remission Induction; Treatment Outcome; Young Adult	2019
Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study. Lupus, 2019, Volume: 28, Issue:5 Topics: Adolescent; Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Lupus Nephritis; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Propensity Score; Remission Induction; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome; Young Adult	2019
Comparison of standard of care treatment with a low steroid and mycophenolate mofetil regimen for lupus nephritis in the ALMS and AURA studies. Lupus, 2019, Volume: 28, Issue:5 Topics: Adolescent; Adult; Aged; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Logistic Models; Lupus Nephritis; Male; Middle Aged; Mycophenolic Acid; Propensity Score; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Standard of Care; Steroids; Time-to-Treatment; Treatment Outcome; Young Adult	2019
Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:10 Topics: Adolescent; Antihypertensive Agents; Biphenyl Compounds; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertension, Renal; Immunosuppressive Agents; Infusions, Intravenous; Irbesartan; Lupus Erythematosus, Systemic; Lupus Nephritis; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Severity of Illness Index; Tacrolimus; Tetrazoles	2013
Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A. Lupus, 2014, Volume: 23, Issue:1 Topics: Cell Proliferation; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Randomized Controlled Trials as Topic; Renal Insufficiency	2014
Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment. The Journal of rheumatology, 2014, Volume: 41, Issue:4 Topics: Adolescent; Adult; Antineoplastic Agents; Cyclosporine; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Longitudinal Studies; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methotrexate; Middle Aged; Ontario; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Proteinuria; Steroids; Time Factors; Treatment Outcome; Urinalysis; Young Adult	2014
Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis. Lupus, 2016, Volume: 25, Issue:4 Topics: Administration, Intravenous; Adolescent; Age Factors; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Logistic Models; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Pulse Therapy, Drug; Recurrence; Remission Induction; Risk Factors; Severity of Illness Index; Singapore; Time Factors; Treatment Outcome	2016
Con: The use of calcineurin inhibitors in the treatment of lupus nephritis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:10 Topics: Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Kidney; Lupus Nephritis; Mycophenolic Acid	2016
Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:10 Topics: Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Maintenance Chemotherapy; Mycophenolic Acid; Proteinuria; Risk Factors; Tacrolimus	2016
Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. The Journal of rheumatology, 2010, Volume: 37, Issue:1 Topics: Adolescent; Adult; Aged; Animals; Antigens, CD19; Antirheumatic Agents; Azathioprine; B-Lymphocytes; Chemokine CXCL13; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Mice; Middle Aged; Receptors, CXCR5; T-Lymphocytes; Young Adult	2010
Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease. Human immunology, 2010, Volume: 71, Issue:9 Topics: Adult; beta 2-Glycoprotein I; Biomarkers; C-Reactive Protein; Creatinine; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Interleukin 1 Receptor Antagonist Protein; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Metabolic Clearance Rate; Methylprednisolone; Middle Aged; Proteinuria; Severity of Illness Index; Young Adult	2010
Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis. Clinical nephrology, 2011, Volume: 76, Issue:2 Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Japan; Kidney; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Proteinuria; Treatment Outcome; Young Adult	2011
Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients. Lupus, 2011, Volume: 20, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Risk Factors; Young Adult	2011
Cerebral lupus in patients whilst on treatment for lupus nephritis with cyclosporine. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2003, Volume: 10, Issue:1 Topics: Abducens Nerve Diseases; Adolescent; Adult; Cyclosporine; Epilepsy, Tonic-Clonic; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Papilledema	2003
[Therapy of lupus nephritis with standard therapeutic protocols and cyclosporine]. Srpski arhiv za celokupno lekarstvo, 2002, Volume: 130 Suppl 3 Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Pulse Therapy, Drug	2002
Cyclosporine A in treatment of membranous lupus nephropathy. Chinese medical journal, 2003, Volume: 116, Issue:12 Topics: Adolescent; Adult; Cyclosporine; Female; Glomerulonephritis, Membranous; Humans; Lupus Nephritis; Male; Prednisone; Retrospective Studies; Treatment Outcome	2003
[IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2004, Volume: 20, Issue:6 Topics: Adolescent; Adult; Cells, Cultured; Cyclosporine; Dexamethasone; Female; Humans; Immunosuppressive Agents; Interleukin-18; Lupus Nephritis; Male; RNA, Messenger; Tacrolimus	2004
Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease. Clinical transplantation, 2005, Volume: 19, Issue:1 Topics: Adult; Calcineurin Inhibitors; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Secondary Prevention; Severity of Illness Index; Tacrolimus	2005
Stevens-Johnson syndrome induced by mizoribine in a patient with systemic lupus erythematosus. Modern rheumatology, 2006, Volume: 16, Issue:2 Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukoencephalopathy, Progressive Multifocal; Lupus Nephritis; Prednisolone; Ribonucleosides; Stevens-Johnson Syndrome; Treatment Outcome	2006
[Lupus nephritis, mycophenolate, and cytomegalovirus infection]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2006, Volume: 26, Issue:1 Topics: Adult; Antibodies, Viral; Cyclophosphamide; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Disease Susceptibility; Female; Humans; Immunocompromised Host; Immunoglobulin M; Immunosuppressive Agents; Lupus Nephritis; Mycophenolic Acid; Nephrotic Syndrome; Prednisone	2006
[Cyclosporine A in treatment of lupus nephritis resistant to cyclophosphamide and mycophenolate mofetil: a case report]. Revista clinica espanola, 2006, Volume: 206, Issue:9 Topics: Adult; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Treatment Outcome	2006
Anti-CD20 antibody treatment in refractory Class IV lupus nephritis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:1 Topics: Adult; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Female; Humans; Lupus Nephritis; Male; Mycophenolic Acid; Nephritis; Rituximab; Treatment Outcome	2007
Treatment of steroid-resistant membranous lupus nephritis with plasmapheresis and low-dose cyclosporine. Pediatric nephrology (Berlin, Germany), 2007, Volume: 22, Issue:4 Topics: Adolescent; Cyclosporine; Drug Resistance; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Plasmapheresis; Steroids	2007
A case of a pregnant woman developing systemic lupus erythematosus during pregnancy. Clinical nephrology, 2007, Volume: 67, Issue:5 Topics: Adult; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Outcome	2007
Clinical problem solving. The girl with the curl. The New England journal of medicine, 1995, Oct-05, Volume: 333, Issue:14 Topics: Acyclovir; Antitubercular Agents; Cyclosporine; Female; Fever; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Middle Aged; Prednisone	1995
Prevention of glomerulosclerosis by early cyclosporine treatment of experimental lupus nephritis. Kidney international, 1994, Volume: 46, Issue:6 Topics: Animals; Autoantibodies; Basement Membrane; Collagen; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glomerulosclerosis, Focal Segmental; Graft vs Host Disease; Kidney Glomerulus; Lupus Nephritis; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Proteinuria; RNA, Messenger; Time Factors	1994
Renal transplantation in systemic lupus erythematosus: a single-center experience with sixty-four cases. American journal of nephrology, 1995, Volume: 15, Issue:2 Topics: Adult; Azathioprine; Cadaver; Cyclosporine; Female; Graft Survival; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Male; Prednisone; Survival Rate; Time Factors; Tissue Donors; Treatment Outcome	1995
[Cyclosporin therapy of patients with systemic lupus erythematosus]. Orvosi hetilap, 1994, Nov-20, Volume: 135, Issue:47 Topics: Adrenal Cortex Hormones; Adult; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Nephrotic Syndrome; Remission Induction; Thrombocytopenia	1994
Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clinical nephrology, 1993, Volume: 40, Issue:3 Topics: Adolescent; Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lupus Nephritis; Prednisone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Time Factors	1993
[The use of measuring serum soluble IL-2 receptor levels in cyclosporine-A treated lupus nephritis]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 1995, Volume: 26, Issue:3 Topics: Adult; Antibodies, Antinuclear; Complement C3; Complement Hemolytic Activity Assay; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Receptors, Interleukin-2	1995
Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Arthritis and rheumatism, 1998, Volume: 41, Issue:4 Topics: Adult; Analysis of Variance; Antibodies; Antibodies, Antinuclear; Antiphospholipid Syndrome; Biopsy; Cadaver; Cell Count; Cell Size; Cyclosporine; Female; Follow-Up Studies; Glomerular Mesangium; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Recurrence; Renal Dialysis; Time Factors; Transplantation Conditioning	1998
Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis. Chinese medical journal, 1997, Volume: 110, Issue:9 Topics: Adolescent; Adult; Biomarkers; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Receptors, Interleukin-2	1997
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy. Clinical nephrology, 1999, Volume: 52, Issue:2 Topics: Adult; Alkylating Agents; Anti-Inflammatory Agents; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Immunoglobulin G; Immunologic Memory; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Pilot Projects; Prednisone; Proteinuria; Renal Plasma Flow, Effective; Sinusitis; Vidarabine	1999
Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A. Rheumatology (Oxford, England), 2000, Volume: 39, Issue:2 Topics: Adult; Antirheumatic Agents; Cyclophosphamide; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Remission Induction	2000
Cyclosporine and tacrolimus-associated thrombotic microangiopathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:4 Topics: Adult; Colon; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Microcirculation; Tacrolimus; Thrombosis	2000
Outcome of renal transplantation under cyclosporine immunosuppression in patients with lupus nephritis. Transplantation proceedings, 2000, Volume: 32, Issue:7 Topics: Adult; Azathioprine; China; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Male; Peritoneal Dialysis; Renal Dialysis; Singapore; Survival Rate; Time Factors; Treatment Outcome	2000
Cyclosporin A in the treatment of patients with nephrotic syndrome. Folia medica, 2000, Volume: 42, Issue:2 Topics: Adult; Amyloidosis; Cyclosporine; Female; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome	2000
Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine. Clinical nephrology, 2001, Volume: 55, Issue:4 Topics: Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid	2001
[Appraisal of renal failure reversing therapies in lupus nephritis]. Zhonghua nei ke za zhi, 2001, Volume: 40, Issue:2 Topics: Administration, Oral; Cohort Studies; Cyclophosphamide; Cyclosporine; Dexamethasone; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Proportional Hazards Models; Recovery of Function; Renal Insufficiency; Retrospective Studies	2001
Renal transplantation in cyclosporine-treated patients with end-stage lupus nephropathy. Transplantation proceedings, 1992, Volume: 24, Issue:5 Topics: Adult; Creatinine; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Lupus Nephritis; Male; Middle Aged; Retrospective Studies; Survival Analysis; Transplantation, Homologous	1992
Recurrence of membranous lupus glomerulonephritis two months after a renal cadaver transplant. Transplantation proceedings, 1992, Volume: 24, Issue:1 Topics: Adult; Azathioprine; Cyclosporine; Humans; Immunosuppression Therapy; Kidney Transplantation; Lupus Nephritis; Male; Platelet Count; Prednisone; Recurrence; Renal Dialysis	1992
Treatment of end stage MRL-1pr/lpr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin A. Journal of clinical & laboratory immunology, 1990, Volume: 32, Issue:2 Topics: Age Factors; Albuminuria; Animals; Antibody Formation; Aziridines; Cyclosporine; Hypergammaglobulinemia; Immunoglobulins; Immunosuppressive Agents; Lupus Nephritis; Lymphoproliferative Disorders; Mice; Mice, Mutant Strains; Organophosphorus Compounds; Sodium Chloride; Structure-Activity Relationship	1990